Диссертация (1140154), страница 25
Текст из файла (страница 25)
Clinical characteristics ofpersistent lone atrial fibrillation in the RACE study. Am J Cardiol., 2004;94(12):p. 1486-90215. Rose NR: Critical cytokine pathways to cardiac inflammation. J InterferonCytokine Res. 2011, 31:705–10216.Rose NR.Learning from myocarditis: mimicry, chaos and black holes.F1000Prime Rep. 2014; 6:25217. Rose NR.Myocarditis:infectionversusautoimmunity. JClinImmunol 2009;29:730-737218.
Rose NR. Predictors of autoimmune disease: autoantibodies and beyond.Autoimmunity 2008; 41:419–428219. Röttgen R, Christiani R, Freyhardt P et al. Magnetic resonance imagingfindings in acute myocarditis and correlation with immunohistologicalparameters. Eur Radiol. 2011 Jun;21(6):1259-66220. Sagar S, Liu P, Cooper LT. Myocarditis.
Lancet 2012; 379: 738-47221.Saphir O. Myocarditis: a general review, with an analysis of two hundred andforty cases. Arch Pathol 1941222. Saraste A, Arola A, Vuorinen T, et al. Cardiomyocyte apoptosis in experimentalcoxsackievirus B3 myocarditis. Cardiovasc Pathol 2003; 12:255–262223.Sarda L, Colin P, Boccara F, et al. Myocarditis in patients with clinicalpresentation of myocardial infarction and normal coronary angiograms. J AmColl Cardiol. 2001;37:786 –792224. Sato Y, Matsumori A, Sasayama S.
Autoantibodies against vimentin in amurine model of myocarditis. Autoimmunity 1994;18:145-148225. Sato Y, Yamada T, Matsumori A. Hepatitis C virus and cardiomyopathy. In:Matsumori A, ed. Cardiomyopathies and Heart Failure: Biomolecular, Infectious,and Immune Mechanisms. Boston, Mass: Kluwer Academic Publishers;2003:325–339154226. Schenk T, Enders M, Pollak S et al.
High prevalence of human parvovirus B19DNA in myocardial autopsy samples from subjects without myocarditis ordilative cardiomyopathy. J Clin Microbiol. 2009; 47(1): p. 106-10227. Schönian U, Crombach M, Maser S, Maisch B. Cytomegalovirus-associatedheart muscle disease. Eur Heart J 1995;16 Suppl O:46-49228.Schultheiss HP. The significance of autoantibodies against the ADP/ATP carrierfor the pathogenesis of myocarditis and dilated cardiomyopathy—clinical andexperimental data. Springer Semin Immunopathol 1989;11:15-30229. Schultheiss HP. The mitochondrium as antigen in inflammatory heart disease.Eur Heart J (Suppl J) 1987;8:203-210230. Schultheiss HP, Kuhl U, Cooper LT. The Management of Myocarditis.
EurHeart J. 2011;32:2616–65231. Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies againstthe adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol1985;17:603-617232. Schultz JC, Hilliard AA, Cooper LT Jr, Rihal CS. Diagnosis and treatment ofviral myocarditis.
Mayo Clin Proc. 2009; 84(11): р. 1001-9233. Schulze K, Becker BF, Schauer R, Schultheiss HP. Antibodies to ADP-ATPcarrier—an autoantigen in myocarditis and dilated cardiomyopathy—impaircardiac function. Circulation 1990;81:959-969234. Schulze K, Heineman FW, Schultheiss HP, Balaban RS. Impairment ofmyocardial calcium homeostasis by antibodies against the adenine nucleotidetranslocator. Cell Calcium 1999;25:361-370235.
Schwimmbeck PL, Schwimmbeck NK, Schultheiss HP, Strauer BE. Mappingof antigenic determinants of the adenine-nucleotide translocator and coxsackie B3virus with synthetic peptides: use for the diagnosis of viral heart disease. ClinImmunol Immunopathol 1993;68:135-140236. Sekiguchi M, Nishizawa M, Nunoda S et al.
Endomyocardial biopsy approachin cases with ventricular arrhythmias. Postgrad Med J. 1992; 68 Suppl 1: S40-3155237. Shauer A, Gotsman I, Keren A et al. Acute viral myocarditis: current conceptsin diagnosis and treatment. Isr Med Assoc J. 2013;15(3):180-5.238. She RC, Hammond EH.Utilityofimmunofluorescenceandelectronmicroscopy in endomyocardial biopsies from patients with unexplained heartfailure. Cardiovasc Pathol 2010;19(4):e99-105239. Schenk T, Enders M, Pollak S, et al. High prevalence of human parvovirus B19DNA in myocardial autopsy samples from subjects without myocarditis ordilative cardiomyopathy.
J Clin Microbiol. 2009 Jan;47(1):106-10240. Spotnitz MD, Lesch M. Idiopathic dilated cardiomyopathy as a latecomplication of healed viral (coxsackie B virus) myocarditis: historical analysis,review of the literature, and a postulated unifying hypothesis. Prog CardiovascDis 2006; 49:42–57241.
Staudt A, Schaper F, Stangl V, et al. Immunohistological changes in dilatedcardiomyopathy induced by immunoadsorption therapy and immunoglobulinsubstitution. Circulation. 2001;103:2681–2686242. Stavrakis S, Kem DC, Patterson E et al. Opposing cardiac effects ofautoantibody activation of beta-adrenergic and M2 muscarinic receptors incardiac-related diseases. Basic Res Cardiol. 2011 Jan;106(1):25-35243. Stewart GC, Lopez-Molina J, Gottumukkala RV et al.
Myocardial parvovirusB19 persistence: lack of association with clinicopathologic phenotype in adultswith heart failure. Circ Heart Fail. 2011; 4(1): p. 71-8244. StöllbergerC,FinstererJ.Arrhythmiasandleftventricularhypertrabeculation/noncompaction. Curr Pharm Des. 2010; 16(26): 2880-94245. Strain JE, Fine EJ, Grose RM, et al. Comparison of myocardial biopsy andgallium-67 imaging for diagnosing myocarditis. Circulation 1983; 68: 208246.
Strain JE, Grose RM, Factor SM, Fisher JD. Results of endomyocardial biopsyin patients with spontaneous ventricular tachycardia but without apparentstructural heart disease. Circulation. 1983; 68(6): р. 1171-81156247. Sugrue DD, Holmes DR Jr, Gersh BJ et al. Cardiac histologic findings inpatients with life-threatening ventricular arrhythmias of unknown origin.
J AmColl Cardiol. 1984; 4(5): p.952-7248. Sun X, Feinberg MW. Knocking Out Viral Myocarditis Reality or a MiRage?Circulation Research. 2012; 111: 388-391249. Takata S, Nakamura H, Umemoto S, et al. Identification of autoantibodies withthe corresponding antigen for repetitive coxsackievirus infection-inducedcardiomyopathy. Circ J 2004;68:677–682250.
Takano H, Nakagawa K, Ishio N et al. Active myocarditis in a patient withchronic active Epstein-Barr virus infection. Int J Cardiol. 2008; 130(1):e11-3251. Takemoto M, Kusachi S, Urabe N, et al. Auto-antibody against adeninenucleotide translocator in dilated cardiomyopathy and myocarditis—incidenceand relation to cardiac function and morphology. Jpn Circ J 1993;57:1150-1158252. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol2005; 95 (11A):3C–8C253.
Towbin JA, Ware SM, Jefferies JL. Heart transplants in pediatric patients: viralinfection as a loss predictor. Future Cardiology. 2010;6:735–41254. Trimpert C, Herda LR, Eckerle LG, etal.Immunoadsorptionindilatedcardiomyopathy: long-term reduction of cardiodepressant antibodies. Eur J ClinInvest 2010;40:685-691255.
Tschope C, Bock CT, Kasner M et al. High prevalence of cardiac parvovirusB19 infection in patients with isolated left ventricular diastolic dysfunction.Circulation 2005;111:879–886256. Uemura A, Morimoto S, Hiramitsu S, Hishida H. Endomyocardial biopsyfindings in 50 patients with idiopathic atrioventricular block: presence ofmyocarditis. Jpn Heart J. 2001; 42(6):р. 691-700257. Ukena C, Kindermann M, Mahfoud F, et al. Diagnostic and prognostic validityof different biomarkers in patients with suspected myocarditis. Clin Res Cardiol.2014 Sep;103(9):743-51157258.
Ukena C, Mahfoud F, Kindermann I, etal. Prognosticelectrocardiographicparameters in patients with suspected myocarditis. Eur J Heart Fail 2011;13:398405259. Unverferth DV, Fetters JK, Unverferth BJ et al. Human myocardial histologiccharacteristics in congestive heart failure.
Circulation 1983;68:1194-1200260. Vanstechelman F, Vandekerckhove H. Cytomegalovirus myocarditis in animmunocompetent patient. Acta Cardiol. 2012; 67(2): р. 257-60261.Vignola PA, Aonuma K, Swaye PS, et al. Lymphocytic myocarditis presentingas unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsyand response to immunosuppression.
J Am Coll Cardiol 1984;4:812-819262. Viskin S, Belhassen B. Polymorphic ventricular tachyarrhythmias in theabsence of organic heart disease: classification, differential diagnosis, andimplications for therapy. Prog Cardiovasc Dis. 1998; 41(1): р. 17-34263. Vorne M, Soini I, Lantto T, Paakkinen S. Technetium-99m HM-PAO-LabeledLeukocytes in Detection of Inflammatory Lesions: Comparison with Gallium-67Citrate. J Nucl Med. 1989;30:1332-1336264. Wallukat G, Kayser A, Wollenberger A.
The beta 1-adrenoceptor as antigen:functional aspects. Eur Heart J 1995;16 Suppl O:85-88265.Weijs B, Pisters R, Nieuwlaat R et al. Idiopathic atrial fibrillation revisited in alarge longitudinal clinical cohort. Europace. 2012; 14(2): p. 184-90266.Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized,placebo controlled study for immunosuppressive treatment of inflammatorydilated cardiomyopathy.
Two-year follow-up results. Circulation 2001;104:39–45267. Wolff PG, Kuhl U, Schultheiss HP. Laminin distribution and autoantibodies tolaminin in dilated cardiomyopathy and myocarditis. Am Heart J 1989;117:13031309268. World heart federation classification and consensus conference on the histoand immunohistopathology of myocarditis. Marburg, April 28–29, 1997 and onviral cardiomyopathy Marburg, October 3–5, 1997.158269. Xiao H, Wang M, Du Y, et al.Agonist-like autoantibodies against calciumchannel in patients with dilated cardiomyopathy. Heart Vessels. 2012Sep;27(5):486-92270. Yamada T, Matsumori A, Tamaki N, et al. Indium-111 antimyosin antibodyimaging and thallium-201 imaging - a comparative myocardial scintigraphicstudy using single-photon emission computed tomography in patients withmyocarditis and dilated cardiomyopathy. Jpn Circ J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
